The Union Cabinet approved the signing of the MoU between the Department of Biotechnology, the Government of India and the Indian Council of Medical Research (ICMR) and the International AIDS Vaccine Initiative IAVI, USA.
Researchers at the Indian Institute of Science (IISc) Bangalore have designed a new class of artificial peptides or miniproteins that they say can render viruses like SARS-CoV-2 inactive.
EXAMIANS